Data / Form D filings / Pharmaxis Ltd.
Pharmaxis Ltd.: Form D filing
Pharmaxis Ltd., a pharmaceuticals company in New South Wales, filed a Form D with the SEC in 2009. The latest, on June 19, 2009, reports $1.4 million sold of a $1.4 million offering to 2 investors.
Find out what Pharmaxis Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2/10 RODBOROUGH ROAD, FRENCHS FOREST, New South Wales, 2086
- Phone
- 61 (2) 9454 7203
- Industry
- Pharmaceuticals
- Entity type
- Other
- Incorporated in
- Australia
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1301357
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 19, 2009 | New notice | $1,394,437 | $1,394,437 | $0 | 2 | Jun 4, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John F. Crapper | Executive Officer | |
| Ian A. McDonald | Executive Officer | |
| Peter C. Farrell | Director | |
| William Delaat | Director | |
| Malcom J. McComas | Director | |
| Brett Charlton | Executive Officer | |
| John Villiger | Director | |
| Alan D. Robertson | Executive Officer, Director | |
| David M. McGarvey | Executive Officer | |
| Denis M. Hanley | Director | |
| Gary J. Phillips | Executive Officer |
Every Form D from the week of Jun 15, 2009 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pharmaxis Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.